Advertisement
CVS vs NVDA
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CVS is a Buy and NVDA is a StrongBuy.
Long-Term Analysis
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
CVS’s FA Score shows that 3 FA rating(s) are green whileNVDA’s FA Score has 3 green FA rating(s).
- CVS’s FA Score: 3 green, 2 red.
- NVDA’s FA Score: 3 green, 2 red.
Short-Term Analysis
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
CVS’s TA Score shows that 6 TA indicator(s) are bullish while NVDA’s TA Score has 4 bullish TA indicator(s).
- CVS’s TA Score: 6 bullish, 4 bearish.
- NVDA’s TA Score: 4 bullish, 3 bearish.
Price Growth
CVS (@Managed Health Care) experienced а -3.79% price change this week, while NVDA (@Semiconductors) price change was +0.16% for the same time period.
The average weekly price growth across all stocks in the @Managed Health Care industry was -8.06%. For the same industry, the average monthly price growth was -5.40%, and the average quarterly price growth was -11.11%.
The average weekly price growth across all stocks in the @Semiconductors industry was +4.40%. For the same industry, the average monthly price growth was +12.11%, and the average quarterly price growth was +0.71%.
Reported Earning Dates
CVS is expected to report earnings on Oct 29, 2025.
NVDA is expected to report earnings on Aug 27, 2025.
Industries' Descriptions
@Managed Health Care (-8.06% weekly)Managed healthcare industry focuses on providing health/medical and disability insurance plans, generally intended to reduce the cost of for-profit health care. The insurance products might be provided through employer-paid (fully or partly) insurance and benefit programs, or through Medicare/Medicaid. Some of the largest providers of managed health care include Aetna, Humana Inc., and Cigna, and UnitedHealthcare.
@Semiconductors (+4.40% weekly)The semiconductor industry manufacturers all chip-related products, including research and development. These chips are used in innumerable electronic devices, including computers, cell phones, smartphones, and GPSs. Intel Corporation, NVIDIA Corp., and Broadcomm are some of the prominent players in this industry. Semiconductor companies usually tend to do well during periods of healthy economic growth, thereby inducing further research and development in the industry – which in turn augurs well for productivity and growth in the economy. In the near future, demand for semiconductor products (and possibly innovation within the segment) should only expand further, with the proliferation of 5G, autonomous vehicles, IoT, and various AI-driven electronics set to herald a new, advanced chapter in the technology-driven world as we know it. With burgeoning prospects comes great competition. In 2015, SIA estimated that U.S. semiconductor industry ranks as the second most competitive U.S. industry out of 2882 U.S. industries designated manufacturers by the U.S. Census Bureau.
| CVS | NVDA | CVS / NVDA | |
| Capitalization | 100B | 3.9T | 3% |
| EBITDA | 18.2B | 91B | 20% |
| Gain YTD | 52.572 | 17.854 | 294% |
| P/E Ratio | 12.33 | 51.61 | 24% |
| Revenue | 358B | 149B | 240% |
| Total Cash | 11.5B | 52.7B | 22% |
| Total Debt | 79.4B | 10.3B | 771% |
CVS | NVDA | ||
|---|---|---|---|
OUTLOOK RATING 1..100 | 16 | 26 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 3 Undervalued | 98 Overvalued | |
PROFIT vs RISK RATING 1..100 | 86 | 10 | |
SMR RATING 1..100 | 78 | 12 | |
PRICE GROWTH RATING 1..100 | 19 | 6 | |
P/E GROWTH RATING 1..100 | 15 | 87 | |
SEASONALITY SCORE 1..100 | 50 | 38 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
CVS's Valuation (3) in the Drugstore Chains industry is significantly better than the same rating for NVDA (98) in the Semiconductors industry. This means that CVS’s stock grew significantly faster than NVDA’s over the last 12 months.
NVDA's Profit vs Risk Rating (10) in the Semiconductors industry is significantly better than the same rating for CVS (86) in the Drugstore Chains industry. This means that NVDA’s stock grew significantly faster than CVS’s over the last 12 months.
NVDA's SMR Rating (12) in the Semiconductors industry is significantly better than the same rating for CVS (78) in the Drugstore Chains industry. This means that NVDA’s stock grew significantly faster than CVS’s over the last 12 months.
NVDA's Price Growth Rating (6) in the Semiconductors industry is in the same range as CVS (19) in the Drugstore Chains industry. This means that NVDA’s stock grew similarly to CVS’s over the last 12 months.
CVS's P/E Growth Rating (15) in the Drugstore Chains industry is significantly better than the same rating for NVDA (87) in the Semiconductors industry. This means that CVS’s stock grew significantly faster than NVDA’s over the last 12 months.
| CVS | NVDA | |
|---|---|---|
| RSI ODDS (%) | 2 days ago 64% | 2 days ago 69% |
| Stochastic ODDS (%) | 2 days ago 62% | 2 days ago 69% |
| Momentum ODDS (%) | 2 days ago 66% | N/A |
| MACD ODDS (%) | 2 days ago 51% | 2 days ago 79% |
| TrendWeek ODDS (%) | 2 days ago 57% | 2 days ago 82% |
| TrendMonth ODDS (%) | 2 days ago 56% | 2 days ago 80% |
| Advances ODDS (%) | 8 days ago 63% | 6 days ago 83% |
| Declines ODDS (%) | 19 days ago 59% | N/A |
| BollingerBands ODDS (%) | 2 days ago 72% | 2 days ago 71% |
| Aroon ODDS (%) | 2 days ago 53% | 2 days ago 88% |
Advertisement
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| CETH | 13.05 | 0.34 | +2.63% |
| 21shares Core Ethereum ETF | |||
| XHE | 81.10 | 1.16 | +1.45% |
| SPDR® S&P Health Care Equipment ETF | |||
| MNBD | 25.48 | 0.05 | +0.20% |
| ALPS Intermediate Municipal Bond ETF | |||
| FTQI | 19.55 | 0.03 | +0.15% |
| First Trust Nasdaq BuyWrite Income ETF | |||
| SCHI | 22.50 | -0.06 | -0.27% |
| Schwab 5-10 Year Corp Bd ETF | |||